Actavis Hong Kong

A Bold New Allergan
On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth. 
Learn more about this exciting combination at www.Actavis.com

News

Archive
Community Involvement

Actavis is committed to being a force for positive change.  For more, please click here.

Decubal®

Decubal® - Expert to dry skin

Over 35 years of dedicated specialism; simple natural ingredients without perfumes or colourings; rigorously tested by dermatologists; Please click here for details.

New From Actavis PANRAZOL (ENTERIC COATED) , Pantoprazole 20/40mg now available in Hong Kong